Given that ErbB3 activation requires both NRG1 and another ErbB co-receptor, we also measured protein expression of EGFR and HER2 in the HNSCC cell lines and patient cohort. This evidence concerns the gene ERBB2 and head and neck squamous cell carcinoma.